BIT Capital’s Sonnet BioTherapeutics SONN Stock Holding History

BIT Capital’s Portfolio SONN Stock Details SONN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-48,358	Closed	-$221K	–	135
2025 Q3	$221K	Buy	+48,358	New	+$214K	0.01%	89

Other funds holding SONN

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

BIT Capital's SONN Position: Q4 2025 in Review

BIT Capital sold out of Sonnet BioTherapeutics (SONN) in Q4 2025, closing a stake of 48,358 shares — an estimated $221K sold.

BIT Capital first reported a position in SONN in Q3 2025 and held it in 1 quarter. The position peaked at $221K in Q3 2025. 1 fund tracked by Wall St. Rank holds SONN as of Q4 2025.

BIT Capital reported no remaining Sonnet BioTherapeutics position as of Q4 2025 after selling out during the quarter.
BIT Capital sold 48,358 Sonnet BioTherapeutics shares in Q4 2025, an estimated $221K.
BIT Capital first reported a position in Sonnet BioTherapeutics in Q3 2025 and held it in 1 quarter.
BIT Capital's Sonnet BioTherapeutics position peaked at $221K in Q3 2025.
1 fund tracked by Wall St. Rank held Sonnet BioTherapeutics as of Q4 2025.

Based on BIT Capital's 13F filing for Q4 2025, filed 11 Feb 2026.